Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivid Seats Inc.SEAT · Entity 7035 | Chief Technology Officer | March 11, 2024 | March 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivid Seats Inc.
Report date March 11, 2024 · Filed March 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 139,925 |
Ending reported balance
After 2024-03-12 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-11 · Exercise / conversion · Acquired 69,734 · Balance 159,360 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. Row 2 · 2024-03-11 · Exercise / conversion · Acquired 10,153 · Balance 169,513 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. Row 3 · 2024-03-12 · Sale · Disposed 29,588 · Balance 139,925 F2: Represents shares sold pursuant to a mandatory "sell to cover" provision of the RSU agreement to satisfy tax withholding obligations arising in connection with the vesting and settlement of the RSUs. F3: Represents the weighted average sale price of multiple transactions at prices ranging from $5.71 to $5.71 per share. The reporting person undertakes to provide, upon request from the staff of the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 139,471 |
Reported balance
After 2024-03-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-11 · Exercise / conversion · Disposed 69,734 · Balance 139,471 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. F4: One-third of the RSUs vested and settled on March 11, 2024. The remainder of the RSUs will vest and settle in quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2026. The RSUs do not have an expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 40,611 |
Reported balance
After 2024-03-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-11 · Exercise / conversion · Disposed 10,153 · Balance 40,611 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. F5: One-third of the RSUs vested and settled on March 11, 2023. The remainder of the RSUs vested and settled or will vest and settle, as applicable, in quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2025. The RSUs do not have an expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.
F2: Represents shares sold pursuant to a mandatory "sell to cover" provision of the RSU agreement to satisfy tax withholding obligations arising in connection with the vesting and settlement of the RSUs.
F3: Represents the weighted average sale price of multiple transactions at prices ranging from $5.71 to $5.71 per share. The reporting person undertakes to provide, upon request from the staff of the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: One-third of the RSUs vested and settled on March 11, 2024. The remainder of the RSUs will vest and settle in quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2026. The RSUs do not have an expiration date.
F5: One-third of the RSUs vested and settled on March 11, 2023. The remainder of the RSUs vested and settled or will vest and settle, as applicable, in quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2025. The RSUs do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2022 Filed Mar 15, 2022 21:02 UTC | Vivid Seats Inc. SEAT · Entity 7035 | GrantRestricted Stock Units · Derivative | 121,832 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011150 · doc4.xml · derivative · entry 1 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,832 Underlying: Class A Common Stock · 121,832 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs will vest and settle with respect to one third of the RSUs on March 11, 2023 and in equal quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2025. The RSUs do not have an expiration date. F2 · derivative.expiration_date: The RSUs will vest and settle with respect to one third of the RSUs on March 11, 2023 and in equal quarterly installments thereafter such that the RSUs will become fully vested on March 11, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 18:54 UTC | Vivid Seats Inc. SEAT · Entity 7035 | SaleClass A Common Stock | 2,139 | $10.50 | $22,460.36 |
DisclosureSEC source: 0000899243-22-002923 · doc4.xml · nonDerivative · entry 2 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111 F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $10.5000 to $10.5514 . The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 18:54 UTC | Vivid Seats Inc. SEAT · Entity 7035 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002923 · doc4.xml · derivative · entry 3 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Class A Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, in 16 equal quarterly installments beginning on January 19, 2022. The RSUs do not have an expiration date. F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, in 16 equal quarterly installments beginning on January 19, 2022. The RSUs do not have an expiration date. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 18:54 UTC | Vivid Seats Inc. SEAT · Entity 7035 | Exercise / conversionClass A Common Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-002923 · doc4.xml · nonDerivative · entry 1 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:46 UTC | Vivid Seats Inc. SEAT · Entity 7035 | GrantStock Option · Derivative | 265,252 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0000899243-21-043699 · doc4.xml · derivative · entry 1 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,252 Underlying: Class A Common Stock · 265,252 shares Expires 2031-11-04 F1 · derivative.exercise_date: The stock options will vest in 16 equal quarterly installments beginning on January 19, 2022, subject to the Reporting Person's continued service to Issuer. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:51 UTC | Vivid Seats Inc. SEAT · Entity 7035 | GrantStock Option · Derivative | 110,273 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000899243-21-041139 · doc4.xml · derivative · entry 3 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,273 Underlying: Class A Common Stock · 110,273 shares Expires 2031-10-19 F3 · derivative.exercise_date: The stock options will vest in 16 equal quarterly installments beginning on January 19, 2022. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:51 UTC | Vivid Seats Inc. SEAT · Entity 7035 | GrantStock Option · Derivative | 110,273 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0000899243-21-041139 · doc4.xml · derivative · entry 2 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,273 Underlying: Class A Common Stock · 110,273 shares Expires 2031-10-19 F3 · derivative.exercise_date: The stock options will vest in 16 equal quarterly installments beginning on January 19, 2022. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:51 UTC | Vivid Seats Inc. SEAT · Entity 7035 | GrantRestricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-041139 · doc4.xml · derivative · entry 1 Wagner Jonathan Miles · CIK 0001880369 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The restricted stock units will vest in 16 equal quarterly installments beginning on January 19, 2022. F2 · derivative.expiration_date: The restricted stock units will vest in 16 equal quarterly installments beginning on January 19, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.